Co-cured fluoroelastomers with improved chemical resistance

US12024575B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12024575-B2
Application numberUS-202218054881-A
CountryUS
Kind codeB2
Filing dateNov 11, 2022
Priority dateFeb 19, 2020
Publication dateJul 2, 2024
Grant dateJul 2, 2024

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Co-cured blends of fluoroelastomers of tetrafluoroethylene-propylene copolymer with cure site monomer and terpolymers of Vinylidene fluoride (VDF), Hexafluoropropylene (HFP) and Tetrafluoroethylene (TFE) with peroxide as initiator and coagent TAIC as crosslinker show improved curing performance, improved mechanical properties and improved compression set as well. The co-cured fluoroelastomers show improved chemical resistance to the solvent aging systems and better retention of mechanical properties after aging at high temperature in the solvents system.

First claim

Opening claim text (preview).

What is claimed is: 1. A co-cured elastomeric blend comprising: about 25-75 parts fluoropolymer A; about 25-75 parts fluoropolymer C, carbon black at about 45 parts per 100 parts of polymers; a peroxide initiator, and a triazine co-crosslinking agent, wherein: fluoropolymer A comprises a polymer of tetrafluoroethylene (TFE), propylene (PP), and cure site monomer (CSM), wherein the fluoropolymer A comprises about 35-55% propylene (PP), wherein the fluoropolymer A has a fluorine content about 57 wt %; fluoropolymer C comprises a polymer of vinylidene fluoride (VDF), tetrafluoroethylene (TFE), and a perfluorinated methyl vinyl ether (PMVE), wherein the fluoropolymer C has a fluorine content about 70 wt %; and fluoropolymer A and fluoropolymer C are crosslinked with the peroxide initiator, and the triazine co-crosslinking agent, wherein the co-cured elastomeric blend exhibits a synergistic effect and improvement in compression set, having a reduced compression set of about 18% when using a composition of 25 wt % fluoropolymer A of the reaction product from a compression set about 37% when using 100% fluoropolymer A, swelling percentage of co-cured fluoroelastomers from 50 parts fluoropolymer A and 50 parts fluoropolymer C after 168-hour aging at 200° C. with hydrocarbon solvents is 18.6% as compared to calculated 21.3%. 2. The blend of claim 1 , wherein the peroxide initiator is 2,5-dimethyl-2,5-di(t-butylperoxy)hexane (DBPH). 3. The blend of claim 2 , wherein the peroxide initiator 2,5-dimethyl-2,5-di(t-butylperoxy)hexane (DBPH) is present at 1 to 5 parts per 100 parts of polymers. 4. The blend of claim 1 , wherein the peroxide initiator is di(t-butylperoxyisopropyl)benzene. 5. The blend of claim 4 , wherein the peroxide initiator di(t-butylperoxyisopropyl)benzene is present at about 1 to 5 parts per 100 parts of polymers. 6. The blend of claim 1 , wherein the triazine cross linking agent is triallyl isocyanurade (TAIC). 7. The blend of claim 6 , wherein TAIC is present at about 1 to 7 parts per 100 parts of polymers. 8. The blend of claim 1 , wherein the CSM is selected from the group consisting of iodine atom and bromine atom. 9. A co-cured elastomeric blend comprising about 25-75 parts fluoropolymer A fluoropolymer C wherein: and about 25-75 parts fluoropolymer A comprises a polymer of tetrafluoroethylene (TFE), propylene (PP), and cure site monomer (CSM), wherein the fluoropolymer A comprises about 35-55% propylene (PP), wherein the fluoropolymer A has a fluorine content about 57 wt %; fluoropolymer C comprises at least one monomer unit of a perfluorinated methyl vinyl ether (PMVE)), wherein the fluoropolymer C has a fluorine content about 70 wt %; and carbon black at about 45 parts per 100 parts of polymers; wherein fluoropolymer A and fluoropolymer C are crosslinked with a peroxide initiator, and a triazine co-crosslinking agent, wherein the co-cured elastomeric blend exhibits a synergistic effect and improvement in compression set, having a reduced compression set of about 18% when using a composition of 25 wt % fluoropolymer A of the co-cured elastomeric blend from a compression set about 37% when using 100% fluoropolymer A, swelling percentage of co-cured fluoroelastomers from 50 parts fluoropolymer A and 50 parts fluoropolymer C after 168-hour aging at 200° C. with hydrocarbon solvents is 18.6% as compared to calculated 21.3%. 10. The blend of claim 9 , wherein the CSM is selected from the group consisting of iodine atom and bromine atom. 11. The blend of claim 9 , wherein the peroxide initiator comprises di(t-butylperoxyisopropyl)benzene and di(t-butylperoxyisopropyl)benzene is present at about 1 to 5 parts per 100 parts of polymer. 12. The blend of claim 9 , wherein the CSM comprises an iodine atom. 13. A co-cured elastomeric blend comprising about 25-75 parts fluoropolymer A and about 25-75 parts fluoropolymer C wherein: fluoropolymer A comprises monomer units and cure site monomer (CSM), wherein the fluoropolymer A comprises about 35-55% propylene (PP), wherein the fluoropolymer A has a fluorine content about 57 wt %; fluoropolymer C comprises at least one monomer unit of a perfluorinated methyl vinyl ether (PMVE)), wherein the fluoropolymer C has a fluorine content about 70 wt %; and carbon black at about 45 parts per 100 parts of polymers; wherein fluoropolymer A and fluoropolymer C are crosslinked with a peroxide initiator, and a triazine co-crosslinking agent, wherein the co-cured elastomeric blend exhibits a synergistic effect and improvement in compression set, having a reduced compression set of about 18% when using a composition of 25 wt % fluoropolymer A of the co-cured elastomeric blend from a compression set about 37% when using 100% fluoropolymer A, swelling percentage of co-cured fluoroelastomers from 50 parts fluoropolymer A and 50 parts fluoropolymer C after 168-hour aging at 200° C. with hydrocarbon solvents is 18.6% as compared to calculated 21.3%. 14. The blend of claim 13 , wherein the CSM is selected from the group consisting of iodine atom and bromine atom.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12024575B2 cover?
Co-cured blends of fluoroelastomers of tetrafluoroethylene-propylene copolymer with cure site monomer and terpolymers of Vinylidene fluoride (VDF), Hexafluoropropylene (HFP) and Tetrafluoroethylene (TFE) with peroxide as initiator and coagent TAIC as crosslinker show improved curing performance, improved mechanical properties and improved compression set as well. The co-cured fluoroelastomers s…
Who is the assignee on this patent?
Cnpc Usa Corp, Beijing Huamei Inc, Beijing Huamel Inc, and 1 more
What technology area does this patent fall under?
Primary CPC classification C08F214/267. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jul 02 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).